These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35818720)

  • 1. High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma.
    Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    Thorac Cancer; 2022 Aug; 13(16):2377-2384. PubMed ID: 35818720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
    Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
    PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis.
    Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L
    Mol Cancer; 2024 Mar; 23(1):47. PubMed ID: 38459511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
    Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
    Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
    Kilvaer TK; Rakaee M; Hellevik T; Østman A; Strell C; Bremnes RM; Busund LT; Dønnem T; Martinez-Zubiaurre I
    PLoS One; 2018; 13(2):e0192157. PubMed ID: 29415055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
    Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
    J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer.
    Zhao Y; Liu Y; Jia Y; Wang X; He J; Zhen S; Wang J; Liu L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3469-3483. PubMed ID: 35951090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
    Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
    Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
    Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
    Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
    Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
    Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
    Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR
    Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between Periostin Expression and Pro-Angiogenic Factors in Non-Small-Cell Lung Carcinoma.
    Wasik A; Podhorska-Okolow M; Dziegiel P; Piotrowska A; Kulus MJ; Kmiecik A; Ratajczak-Wielgomas K
    Cells; 2024 Aug; 13(17):. PubMed ID: 39272978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder.
    Calvete J; Larrinaga G; Errarte P; Martín AM; Dotor A; Esquinas C; Nunes-Xavier CE; Pulido R; López JI; Angulo JC
    Hum Pathol; 2019 Sep; 91():61-68. PubMed ID: 31279874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
    Moreno-Ruiz P; Corvigno S; Te Grootenhuis NC; La Fleur L; Backman M; Strell C; Mezheyeuski A; Hoelzlwimmer G; Klein C; Botling J; Micke P; Östman A
    Lung Cancer; 2021 May; 155():10-19. PubMed ID: 33706022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
    Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
    Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.
    Cords L; Engler S; Haberecker M; Rüschoff JH; Moch H; de Souza N; Bodenmiller B
    Cancer Cell; 2024 Mar; 42(3):396-412.e5. PubMed ID: 38242124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549 
by Supressing Stat3-EMT via CAFs Exosomes].
    Wang S; Cui J; Zhang K; Gu J; Zheng Y; Zhang B; Shi L
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):384-393. PubMed ID: 34024061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cancer-associated fibroblasts on survival of patients with ampullary carcinoma.
    Takagi K; Noma K; Nagai Y; Kikuchi S; Umeda Y; Yoshida R; Fuji T; Yasui K; Tanaka T; Kashima H; Yagi T; Fujiwara T
    Front Oncol; 2023; 13():1072106. PubMed ID: 37007101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer.
    Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X
    Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.